Mynd Life SciencesOct 7, 2021MYND Life Sciences Announces Diagnostic Division with Formation of Wholly-Owned Subsidiary – MMYND Diagnostics was formed to commercialize proprietary biomarker diagnostic tests for patients suffering from MDD, TRD and other...
Mynd Life SciencesSep 29, 2021MYND Life Sciences Inc. Announces RSU GrantVANCOUVER, BC, Sept. 29, 2021 /CNW/ – MYND Life Sciences Inc. (“MYND” or the “Company“), has granted an aggregate of 234,192 restricted...
Mynd Life SciencesSep 9, 2021MYND Life Sciences Announces Closing of Fully Subscribed $3 Million Convertible Debenture Unit OfferVANCOUVER, BC, Sept. 9, 2021 /CNW/ – MYND Life Sciences Inc. (CSE: MYND) (OTC: MYNDF) (“MYND” or the “Company“) is pleased to announce,...